Select Page

The McKinsey & Company logo is displayed at the 54th International Paris Airshow at Le Bourget Airport near Paris, France, June 21, 2023. 

Benoit Tessier | Reuters

McKinsey & Co. agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to increase sales of its addictive opioid drug OxyContin, a court filing said Friday.

A former top partner at McKinsey also agreed to plead guilty to obstruction of justice in the probe, according to court filings.

CNBC has requested comment from McKinsey.

This is breaking news. Please refresh for updates.

Share it on social networks